415 related articles for article (PubMed ID: 34087694)
1. Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway.
Zhao X; Kong D; Zhou Q; Wei G; Song J; Liang Y; Du G
Biomed Pharmacother; 2021 Aug; 140():111556. PubMed ID: 34087694
[TBL] [Abstract][Full Text] [Related]
2. Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson's disease model.
Salari Z; Ashabi G; Fartoosi A; Fartoosi A; Shariatpanahi M; Aghsami M; Montazeri H; Kheradmand A
BMC Pharmacol Toxicol; 2023 Nov; 24(1):60. PubMed ID: 37936189
[TBL] [Abstract][Full Text] [Related]
3. Baicalein Protects against Rotenone-Induced Neurotoxicity through Induction of Autophagy.
Kuang L; Cao X; Lu Z
Biol Pharm Bull; 2017 Sep; 40(9):1537-1543. PubMed ID: 28659545
[TBL] [Abstract][Full Text] [Related]
4. Baicalein exerts anti-neuroinflammatory effects to protect against rotenone-induced brain injury in rats.
Zhang X; Yang Y; Du L; Zhang W; Du G
Int Immunopharmacol; 2017 Sep; 50():38-47. PubMed ID: 28623717
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective action of agmatine in rotenone-induced model of Parkinson's disease: Role of BDNF/cREB and ERK pathway.
Bilge SS; Günaydin C; Önger ME; Bozkurt A; Avci B
Behav Brain Res; 2020 Aug; 392():112692. PubMed ID: 32479847
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid-based therapeutics ameliorate rotenone-induced motor and depressive behaviors in parkinsonian male mice via controlling neuroinflammation and activating Nrf2-BDNF-dopaminergic signaling pathways.
Pingale TD; Gupta GL
Toxicol Mech Methods; 2024 May; 34(4):335-349. PubMed ID: 38084769
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis.
Zhang X; Du L; Zhang W; Yang Y; Zhou Q; Du G
Sci Rep; 2017 Aug; 7(1):9968. PubMed ID: 28855526
[TBL] [Abstract][Full Text] [Related]
8. Oleuropein confers neuroprotection against rotenone-induced model of Parkinson's disease via BDNF/CREB/Akt pathway.
Singh R; Zahra W; Singh SS; Birla H; Rathore AS; Keshri PK; Dilnashin H; Singh S; Singh SP
Sci Rep; 2023 Feb; 13(1):2452. PubMed ID: 36774383
[TBL] [Abstract][Full Text] [Related]
9. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease.
Hu Q; Uversky VN; Huang M; Kang H; Xu F; Liu X; Lian L; Liang Q; Jiang H; Liu A; Zhang C; Pan-Montojo F; Zhu S
Biochim Biophys Acta; 2016 Oct; 1862(10):1883-90. PubMed ID: 27425033
[TBL] [Abstract][Full Text] [Related]
10. Mismatch between changes in baicalein-induced memory-related biochemical parameters and behavioral consequences in mouse.
Park SJ; Kim DH; Kim JM; Shin CY; Cheong JH; Ko KH; Ryu JH
Brain Res; 2010 Oct; 1355():141-50. PubMed ID: 20691671
[TBL] [Abstract][Full Text] [Related]
11. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
Zhu G; Li J; He L; Wang X; Hong X
Br J Pharmacol; 2015 May; 172(9):2354-68. PubMed ID: 25560396
[TBL] [Abstract][Full Text] [Related]
12. Licorisoflavan A Exerts Antidepressant-Like Effect in Mice: Involvement of BDNF-TrkB Pathway and AMPA Receptors.
Xiao D; Liu L; Li Y; Ruan J; Wang H
Neurochem Res; 2019 Sep; 44(9):2044-2056. PubMed ID: 31278631
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1α and BDNF/CREB pathways.
Chen H; Cao J; Zha L; Wang P; Liu Z; Guo B; Zhang G; Sun Y; Zhang Z; Wang Y
Aging (Albany NY); 2020 Jul; 12(14):14897-14917. PubMed ID: 32710729
[TBL] [Abstract][Full Text] [Related]
14. [Neuroprotective effect of baicalein in patients with Parkinson's disease].
Yu X; He G; Du G
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(4):421-5. PubMed ID: 22667137
[TBL] [Abstract][Full Text] [Related]
15. Spermine protects from LPS-induced memory deficit via BDNF and TrkB activation.
Frühauf-Perez PK; Temp FR; Pillat MM; Signor C; Wendel AL; Ulrich H; Mello CF; Rubin MA
Neurobiol Learn Mem; 2018 Mar; 149():135-143. PubMed ID: 29458098
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of baicalein in animal models of Parkinson's disease: A systematic review of experimental studies.
Zhu Q; Zhuang X; Lu J
Phytomedicine; 2019 Mar; 55():302-309. PubMed ID: 30385133
[TBL] [Abstract][Full Text] [Related]
17. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease.
Tuon T; Valvassori SS; Dal Pont GC; Paganini CS; Pozzi BG; Luciano TF; Souza PS; Quevedo J; Souza CT; Pinho RA
Brain Res Bull; 2014 Sep; 108():106-12. PubMed ID: 25264157
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade.
Mohamed YT; Salama A; Rabie MA; Abd El Fattah MA
Int Immunopharmacol; 2023 Jan; 114():109571. PubMed ID: 36527875
[TBL] [Abstract][Full Text] [Related]
19. Brain polar phenol content, behavioural and neurochemical effects of Corinthian currant in a rotenone rat model of Parkinson's disease.
Fanarioti E; Tsarouchi M; Vasilakopoulou PB; Chiou A; Karvelas M; Karathanos VT; Dermon CR
Nutr Neurosci; 2023 Jul; 26(7):652-666. PubMed ID: 35656969
[TBL] [Abstract][Full Text] [Related]
20. Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: Role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axis.
Khidr HY; Hassan NF; Abdelrahman SS; El-Ansary MR; El-Yamany MF; Rabie MA
Int Immunopharmacol; 2023 Dec; 125(Pt B):111207. PubMed ID: 37956489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
